Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women


To date, the effects of long-term testosterone (T) administration on the human vagina are not completely understood. Thus, the aim of this study was to investigate the effects of long-term T treatment on vaginal tissue histology, estrogen receptor alpha (ERα) and beta (ERβ) expression and proliferation in female to male transsexual subjects (FtM). We compared vaginal samples from FtM subjects with those of premenopausal women (PrM) and postmenopausal women (M) not receiving any hormonal treatment for at least 2 years. Vaginal tissue samples from 16 FtM subjects treated with T (intramuscular injections of 100 mg Testoviron Depot/7–10 days for at least 1 year), undergoing sex reassignment surgery, and 16 PrM and 16 M subjects undergoing a vaginal hysterectomy for prolapse, were collected. For each sample, morphology, glycogen content, proliferation (ki-67), ERα and ERβ expression were evaluated. Vaginal samples from FtM showed a loss of normal architecture of the epithelium, intermediate and superficial layers were completely lost, and glycogen content was depleted. T administration resulted in a strong proliferation reduction when compared with both M and PrM subjects. Stromal and epithelial ERα as well as ERβ were significantly decreased in FtM when compared with PrM subjects. In conclusion, our data suggests that systemic T administration at supraphysiological dosage, determines profound changes in histomorphology and reduces ERs expression and proliferation of vaginal epithelium.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5


  1. Kingsberg SA, Simon JA, Goldstein I . The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2008; 2: 182–193.

    Article  Google Scholar 

  2. Goldstein I . Editorial comments on ‘the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women’. J Sex Med 2008; 2: 177–178.

    Article  Google Scholar 

  3. Stuckey BG . Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones. J Sex Med 2008; 5: 2282–2290.

    Article  CAS  Google Scholar 

  4. West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM . Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 2008; 168: 1441–1449.

    Article  Google Scholar 

  5. Dennerstein L, Koochaki P, Barton I, Graziottin A . Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006; 3: 212–222.

    Article  Google Scholar 

  6. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M et alAPHRODITE Study Team. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008; 359: 2005–2017.

    Article  CAS  Google Scholar 

  7. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226–5233.

    Article  CAS  Google Scholar 

  8. Bolour S, Braunstein G . Testosterone therapy in women: a review. Int J Impot Res 2005; 17: 399–408.

    Article  CAS  Google Scholar 

  9. Miller N, Bédard YC, Cooter NB, Shaul DL . Histological changes in the genital tract in transsexual women following androgen therapy. Histopathology 1986; 10: 661–669.

    Article  CAS  Google Scholar 

  10. Munarriz R, Kim SW, Kim NN, Traish A, Goldstein I . A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model. J Urol 2003; 170: S40–S44, discussion S44-5.

    Article  CAS  Google Scholar 

  11. Pessina MA, Hoyt RF, Goldstein I, Traish AM . Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology 2006; 147: 61–69.

    Article  CAS  Google Scholar 

  12. Perrone AM, Cerpolini S, Maria Salfi NC, Ceccarelli C, De Giorgi LB, Formelli G et al. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. J Sex Med 2009; 6: 3193–3200.

    Article  CAS  Google Scholar 

  13. Traish AM, Botchevar E, Kim NN . Biochemical factors modulating female genital sexual arousal physiology. J Sex Med 2010; 7: 2925–2946.

    Article  CAS  Google Scholar 

  14. Meriggiola MC, Armillotta F, Costantino A, Altieri P, Saad F, Kalhorn T et al. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals. J Sex Med 2008; 5: 2442–2453.

    Article  CAS  Google Scholar 

  15. Meriggiola MC, Jannini EA, Lenzi A, Maggi M, Manieri C . Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. Eur J Endocrinol 2010; 162: 831–833.

    Article  CAS  Google Scholar 

  16. Godano A, Maggi M, Jannini E, Meriggiola MC, Ghigo E, Todarello O et al. SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders. J Endocrinol Invest 2009; 32: 857–864, No abstract available.

    Article  CAS  Google Scholar 

  17. Berra M, Armillotta F, D’Emidio L, Costantino A, Martorana G, Pelusi G et al. Testosterone decreases adiponectin levels in female to male transsexuals. Asian J Androl 2006; 8: 725–729.

    Article  CAS  Google Scholar 

  18. American College of Obstetricians and Gynecologists. Frequently asked questions about hormone replacement therapy. 2004. Available at:

  19. Henriques HN, de Carvalho AC, Soares Filho PJ, Pantaleão JA, Guzmán-Silva MA . Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats. Int J Exp Pathol 2011; 92: 266–271.

    Article  CAS  Google Scholar 

  20. Walker RA . Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 2006; 49: 406–410.

    Article  CAS  Google Scholar 

  21. Boskey ER, Cone RA, Whaley KJ, Moench TR . Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001; 16: 1809–1813.

    Article  CAS  Google Scholar 

  22. Hofling M, Hirschberg AL, Skoog L, Tani E, Hägerström T, von Schoultz B . Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 2007; 14: 183–190.

    Article  Google Scholar 

  23. Cunha GR, Cooke PS, Kurita T . Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 2004; 67: 417–434.

    Article  CAS  Google Scholar 

  24. Tsai PS, Uchima FD, Hamamoto ST, Bern HA . Proliferation and differentiation of prepubertal mouse vaginal epithelial cells in vitro and the specificity of estrogen-induced growth retardation. In Vitro Cell Dev Biol 1991; 27A: 461–468.

    Article  CAS  Google Scholar 

  25. Cooke PS, Uchima F-DA, Fujii DK, Bern HA, Cunha GR . Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma. Proc Natl Acad Sci USA 1986; 83: 2109–2113.

    Article  CAS  Google Scholar 

  26. Buchanan DL, Kurita T, Taylor JA, Lubahn DB, Cunha GR, Cooke PS . Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology 1998; 139: 4345–4352.

    Article  CAS  Google Scholar 

  27. Baldassarre M, Perrone AM, Giannone FA, Armillotta F, Battaglia C, Costantino A et al. Androgen receptor expression in the human vagina under different physiological and treatment conditions. Int J Impot Res 2013; 25: 7–11.

    Article  CAS  Google Scholar 

  28. Kim SW, Kim NN, Jeong SJ, Munarriz R, Goldstein I, Traish AM . Modulation of rat vaginal blood flow and estrogen receptor by estradiol. J Urol 2004; 172 (4 Pt 1): 1538–1543.

    Article  CAS  Google Scholar 

  29. Xie Z, Shi H, Zhou C, Dong M, Hong L, Jin H . Alterations of estrogen receptor-alpha and-beta in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2007; 134: 254–258.

    Article  CAS  Google Scholar 

  30. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M . Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127: 4277–4291.

    CAS  PubMed  Google Scholar 

  31. Vignozzi L, Filippi S, Morelli A, Comeglio P, Cellai I, Sarchielli E et al. Testosterone/estradiol ratio regulates no-induced bladder relaxation and responsiveness to pde5 inhibitors. J Sex Med 2012; 9: 3028–3040.

    Article  CAS  Google Scholar 

  32. Witherby S, Johnson J, Demers L, Mount S, Littenberg B, Maclean CD et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist 2011; 16: 424–431.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to M C Meriggiola.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on International Journal of Impotence Research website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baldassarre, M., Giannone, F., Foschini, M. et al. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women. Int J Impot Res 25, 172–177 (2013).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • female to male
  • sex steroids receptors
  • testosterone therapy
  • vaginal atrophy
  • vagina

This article is cited by


Quick links